FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048777956> ?p ?o ?g. }

• W3048777956 endingPage "3787" @default.
• W3048777956 startingPage "3776" @default.
• W3048777956 abstract "Abstract Factors contributing to hematopoietic recovery following chimeric antigen receptor (CAR) T-cell therapy have not been well studied. In an analysis of 83 patients with hematologic malignancies treated with CAR T-cell therapy, we describe patterns of hematopoietic recovery and evaluate potentially associated factors. We included patients who received axicabtagene ciloleucel (n = 30) or tisagenlecleucel (n = 10) for B-cell lymphoma, CD19-28z CAR T therapy for B-cell acute lymphoblastic leukemia (NCT01044069; n = 37), or B-cell maturation antigen targeting CAR T cells for multiple myeloma (NCT03070327; n = 6). Patients treated with CAR T cells who had not progressed, died, or received additional chemotherapy had “recovered” (per definition in Materials and methods section) hemoglobin, platelet, neutrophil, and white blood cell counts at rates of 61%, 51%, 33%, and 28% at month 1 postinfusion and 93%, 90%, 80%, and 59% at month 3 postinfusion, respectively. Univariate analysis showed that increasing grade of immune effector cell–associated neurological syndrome (ICANS), baseline cytopenias, CAR construct, and higher peak C-reactive protein or ferritin levels were statistically significantly associated with a lower likelihood of complete count recovery at 1 month; a similar trend was seen for cytokine release syndrome (CRS). After adjustment for baseline cytopenia and CAR construct, grade ≥3 CRS or ICANS remained significantly associated with the absence of complete count recovery at 1 month. Higher levels of vascular endothelial growth factor and macrophage-derived chemokines, although not statistically significant, were seen patients without complete count recovery at 1 month. This remains to be studied further in larger prospective studies." @default.
• W3048777956 created "2020-08-18" @default.
• W3048777956 creator A5000287888 @default.
• W3048777956 creator A5000852934 @default.
• W3048777956 creator A5001409814 @default.
• W3048777956 creator A5009611651 @default.
• W3048777956 creator A5011077747 @default.
• W3048777956 creator A5021595775 @default.
• W3048777956 creator A5023530852 @default.
• W3048777956 creator A5027007983 @default.
• W3048777956 creator A5033055418 @default.
• W3048777956 creator A5034628611 @default.
• W3048777956 creator A5034814142 @default.
• W3048777956 creator A5042329534 @default.
• W3048777956 creator A5044552886 @default.
• W3048777956 creator A5047384277 @default.
• W3048777956 creator A5051833337 @default.
• W3048777956 creator A5052659722 @default.
• W3048777956 creator A5056533475 @default.
• W3048777956 creator A5060701531 @default.
• W3048777956 creator A5064294460 @default.
• W3048777956 creator A5065556543 @default.
• W3048777956 creator A5070096873 @default.
• W3048777956 creator A5074706721 @default.
• W3048777956 creator A5077473098 @default.
• W3048777956 creator A5091643041 @default.
• W3048777956 date "2020-08-11" @default.
• W3048777956 modified "2023-10-17" @default.
• W3048777956 title "Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies" @default.
• W3048777956 cites W2044827358 @default.
• W3048777956 cites W2099570622 @default.
• W3048777956 cites W2129702476 @default.
• W3048777956 cites W2130338247 @default.
• W3048777956 cites W2754562068 @default.
• W3048777956 cites W2756071038 @default.
• W3048777956 cites W2763751953 @default.
• W3048777956 cites W2773804840 @default.
• W3048777956 cites W2787301955 @default.
• W3048777956 cites W2787621143 @default.
• W3048777956 cites W2793826339 @default.
• W3048777956 cites W2795019304 @default.
• W3048777956 cites W2808166290 @default.
• W3048777956 cites W2892326722 @default.
• W3048777956 cites W2899318000 @default.
• W3048777956 cites W2899403047 @default.
• W3048777956 cites W2903062212 @default.
• W3048777956 cites W2903225254 @default.
• W3048777956 cites W2904298620 @default.
• W3048777956 cites W2905039524 @default.
• W3048777956 cites W2905418815 @default.
• W3048777956 cites W2905654445 @default.
• W3048777956 cites W2906581363 @default.
• W3048777956 cites W2916606137 @default.
• W3048777956 cites W2938308258 @default.
• W3048777956 cites W2943335541 @default.
• W3048777956 cites W2945894787 @default.
• W3048777956 cites W2946366893 @default.
• W3048777956 cites W2950868969 @default.
• W3048777956 cites W2967884832 @default.
• W3048777956 cites W2969216121 @default.
• W3048777956 cites W2984594015 @default.
• W3048777956 cites W3001742624 @default.
• W3048777956 cites W3007888754 @default.
• W3048777956 cites W3015514251 @default.
• W3048777956 cites W4243475288 @default.
• W3048777956 doi "https://doi.org/10.1182/bloodadvances.2020002509" @default.
• W3048777956 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7422135" @default.
• W3048777956 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32780846" @default.
• W3048777956 hasPublicationYear "2020" @default.
• W3048777956 type Work @default.
• W3048777956 sameAs 3048777956 @default.
• W3048777956 citedByCount "144" @default.
• W3048777956 countsByYear W30487779562020 @default.
• W3048777956 countsByYear W30487779562021 @default.
• W3048777956 countsByYear W30487779562022 @default.
• W3048777956 countsByYear W30487779562023 @default.
• W3048777956 crossrefType "journal-article" @default.
• W3048777956 hasAuthorship W3048777956A5000287888 @default.
• W3048777956 hasAuthorship W3048777956A5000852934 @default.
• W3048777956 hasAuthorship W3048777956A5001409814 @default.
• W3048777956 hasAuthorship W3048777956A5009611651 @default.
• W3048777956 hasAuthorship W3048777956A5011077747 @default.
• W3048777956 hasAuthorship W3048777956A5021595775 @default.
• W3048777956 hasAuthorship W3048777956A5023530852 @default.
• W3048777956 hasAuthorship W3048777956A5027007983 @default.
• W3048777956 hasAuthorship W3048777956A5033055418 @default.
• W3048777956 hasAuthorship W3048777956A5034628611 @default.
• W3048777956 hasAuthorship W3048777956A5034814142 @default.
• W3048777956 hasAuthorship W3048777956A5042329534 @default.
• W3048777956 hasAuthorship W3048777956A5044552886 @default.
• W3048777956 hasAuthorship W3048777956A5047384277 @default.
• W3048777956 hasAuthorship W3048777956A5051833337 @default.
• W3048777956 hasAuthorship W3048777956A5052659722 @default.
• W3048777956 hasAuthorship W3048777956A5056533475 @default.
• W3048777956 hasAuthorship W3048777956A5060701531 @default.
• W3048777956 hasAuthorship W3048777956A5064294460 @default.
• W3048777956 hasAuthorship W3048777956A5065556543 @default.
• W3048777956 hasAuthorship W3048777956A5070096873 @default.

• next